Petros Family Wealth LLC Purchases New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Petros Family Wealth LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,071 shares of the medical equipment provider's stock, valued at approximately $1,081,000. Intuitive Surgical comprises approximately 1.2% of Petros Family Wealth LLC's investment portfolio, making the stock its 21st biggest position.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC raised its position in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the period. Norges Bank purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $2,401,493,000. Finally, Invesco Ltd. grew its stake in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after purchasing an additional 295,025 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Finally, Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $611.81.

Intuitive Surgical Stock Up 1.1 %

NASDAQ:ISRG traded up $5.06 on Thursday, reaching $486.40. 894,346 shares of the company's stock were exchanged, compared to its average volume of 2,187,223. The firm has a market capitalization of $173.24 billion, a price-to-earnings ratio of 75.88, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business has a fifty day moving average of $526.67 and a 200-day moving average of $532.10.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.